SCHEMBL4474983

SCHEMBL4474983

Cc1cc(NC(=O)C(C)(C)NC(=O)c2ccc(Br)s2)ccc1N1CCNS1(=O)=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F10 P00742 4/20 0.53
AR P10275 4/20 0.52
MEN1 O00255 6/20 0.38
KMT2A Q03164 6/20 0.38
MAPT P10636 3/20 0.38
NPSR1 Q6W5P4 1/20 0.38
USP2 O75604 1/20 0.37
HSD17B10 Q99714 1/20 0.37
NPC1 O15118 5/20 0.37
RAB9A P51151 5/20 0.37
NFKB1 P19838 3/20 0.37
NFKB2 Q00653 3/20 0.37
RELA Q04206 3/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
CASP3 P42574 2/20 0.37
SENP7 Q9BQF6 2/20 0.37
POLB P06746 1/20 0.37
SENP8 Q96LD8 1/20 0.37
SENP6 Q9GZR1 1/20 0.37
TP53 P04637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4468411 0.95 F10 (0.51) F10ARMEN1KMT2AMAPT
SCHEMBL4473885 0.88 F10 (0.51) F10ARMEN1KMT2AMAPT
SCHEMBL5507256 0.86 F10 (0.39) F10ARMAPTTP53PIK3C3
SCHEMBL4459521 0.85 F10 (0.53) F10ARMEN1KMT2AMAPT
SCHEMBL4476975 0.84 F10 (0.53) F10ARMEN1KMT2AMAPT
SCHEMBL4465457 0.83 F10 (0.52) F10ARMEN1KMT2AMAPT
SCHEMBL4477334 0.83 F10 (0.59) F10ARMEN1KMT2AMAPT
SCHEMBL4473630 0.81 F10 (0.57) F10ARMEN1KMT2AMAPT
SCHEMBL4467671 0.80 F10 (0.56) F10ARMEN1KMT2AMAPT
SCHEMBL4459934 0.79 F10 (0.53) F10ARMEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7476663-B2 Substituted thiophene carboxamides BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-01-13 US disclosed
US-20050277628-A1 Substituted thiophene carboxamides BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2005-12-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050277628-A1 Substituted thiophene carboxamides OTC, SLC22A8, DDC F10 2132/4885AR 2088/4885MEN1 2017/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.